Murchinson’s Strongbridge Biopharma plc. SBBP Stock Holding History

Murchinson’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-147,555	Closed	-$438K	–	143
2021 Q2	$438K	Buy	+147,555	New	+$390K	0.16%	61

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Murchinson's SBBP Position: Q3 2021 in Review

Murchinson sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 147,555 shares — an estimated $438K sold.

Murchinson first reported a position in SBBP in Q2 2021 and held it in 1 quarter. The position peaked at $438K in Q2 2021. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

Murchinson reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
Murchinson sold 147,555 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $438K.
Murchinson first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 1 quarter.
Murchinson's Strongbridge Biopharma plc. position peaked at $438K in Q2 2021.
49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on Murchinson's 13F filing for Q3 2021, filed 15 Nov 2021.